In an attempt to reduce polyethylene-induced osteolysis and improve implant longevity, there has been renewed interest in the use of metal-on-metal (MoM) arthroplasty. The improved wear performance profiles result in substantially less wear debris and subsequent periprosthetic osteolysis ([@CIT0029], [@CIT0059], [@CIT0066]). As a result, many MoM implants have been shown to last over 2 decades, or are still functioning in patients who received the implant at a young age ([@CIT0058]). MoM bearings are now commonly used in younger patients where implant longevity is particularly important ([@CIT0031]). However, metal ion toxicity---both locally in the periprosthetic space and systemically---remains a concern ([@CIT0033], [@CIT0032], [@CIT0024], [@CIT0025]). It has been well established that substantial levels of metallic products can be transferred into the host environment from implanted metallic devices ([@CIT0017], [@CIT0049]). Cobalt-chrome-molybdenum is the alloy used for MoM bearings, due to its wear performance profile. Cobalt and chromium ions are produced as a result of the MoM articulation ([@CIT0016]). In this study, we have focused on the effect of cobalt ions, as we have previously demonstrated a greater level of toxicity of these ions compared to chromium ions when in contact with primary human osteoblasts ([@CIT0054]).

Local effects of cobalt ions in the periprosthetic tissue include cytotoxicity, and these ions have been demonstrated to induce apoptosis, necrosis, and chemokine secretion (interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1)) and tumor necrosis factor-α secretion in both macrophages and osteoblasts ([@CIT0049], [@CIT0013], [@CIT0014], [@CIT0015], [@CIT0034], [@CIT0046], [@CIT0053], [@CIT0023], [@CIT0039], [@CIT0054]). In comparison, the systemic effect of metal ions is relatively unknown. Cobalt ions can be generated in the periprosthetic space due to electrochemical corrosion of metal particles or possibly as a result of phagocytosis of CoCrMo particles by cells and exposure of these particles to a series of oxidative mechanisms designed to destroy the foreign body ([@CIT0026], [@CIT0044], [@CIT0011]). The ions then bind to serum proteins (mainly albumin) and are transported systemically before being excreted in the urine ([@CIT0013], [@CIT0065], [@CIT0055], Grubl et al. 2007). Elevated serum levels of cobalt ions have been demonstrated, but the clinical implications of this have not been fully elucidated yet ([@CIT0014], [@CIT0053]).

The cells chosen for our experiments are representative of 3 main organ systems that can be susceptible to chronic inflammation: renal, gastrointestinal, and respiratory. Cobalt ions are excreted through the renal and gastrointestinal systems ([@CIT0016]). In the distal tubule of the kidney, proximal tubule epithelial cells are in direct contact with cobalt ions during excretion. The gastrointestinal epithelial cells are avascular but are in intimate contact with the gastric submucosa and colon submucosa, which possess arterial and venus plexuses that supply and drain the vessels of the mucosa, respectively. The diffuse blood supply within this layer enables the passage of ions to the mucosa. The respiratory system was also investigated, as previous studies have shown an increased incidence of asthma and inflammatory conditions following occupational exposure to cobalt ([@CIT0051]). The respiratory system can be divided into two major parts, a conducting portion and a respiratory portion. For the purpose of our experiments, two varieties of cells representative of each portion were chosen.

Neutrophils and monocytes represent the first line of defense against acute inflammatory processes. As the cobalt ions are in intimate contact with these constituents of blood during their transit through the vascular system, we also wanted to examine the effect that these ions have on monocytes and neutrophils.

The aim of our study was to investigate the in vitro effect of cobalt ions on a variety of human cell lines representing potential systemic targets of cobalt ion toxicity. The primary aim was to examine the inflammatory response elicited by cobalt ions when exposed to these cells. To achieve this, we examined IL-8 and MCP-1, two immediate-early stress response chemokines that function to attract neutrophils and monocytes respectively. These chemokines initiate the progression of an inflammatory response, which is governed to a large extent by the continued availability of infiltrating leukocytes that are recruited to the site of inflammatory injury. Previous studies have shown that cobalt ions lead to increased chemokine secretion in primary human osteoblasts with the potential to induce osteolysis by recruiting inflammatory leukocytes ([@CIT0054]). We hypothesized that cobalt ions have a similar pro-inflammatory effect on other systemic cell lines, thus potentially inducing an inflammatory condition or exacerbate an existing one. Specifically, we investigated the production of proinflammatory chemokines (IL-8 and MCP-1) by these cell types in response to cobalt ion exposure.

Materials and methods {#ss2}
=====================

Cell culture and metal ion exposure ([Table 1](#T1){ref-type="table"}) {#ss3}
----------------------------------------------------------------------

A variety of cell lines were chosen to represent different organ systems. The cells were cultured as monolayers in their respective recommended media, in 6-well plates. All experiments were carried out once the cells had reached 80--90% confluence and at their optimal passage number. The cells were stimulated with 10 parts per million (ppm) cobalt ions (Co²^+^) (CoCl~2~; Sigma-Aldrich) in growth medium ([Table 1](#T1){ref-type="table"}). This concentration has been used in vitro by other authors in assessing the effect of cobalt ions on macrophages ([@CIT0013], [@CIT0015], [@CIT0053], [@CIT0034], [@CIT0023]). Each experiment was carried out in triplicate. Supernatants were collected at 4, 12, 24, and 48 h. The medium alone without Co^2+^ was used as a negative control for each cell line.

###### 

Cell cultures and culture medium used

  Cell type     Medium                                                       Passage no.
  ------------- ------------------------------------------------------------ -------------
  HK-2          DMEM/F12 (1:1), EGF, 10% FBS                                 12
  AGS           Ham\'s F12, L-glutamine, 10% FBS                             18
  T-84          DMEM/F12 (1:1), L-glutamine, 10% FBS                         24
  SAE           Small Airway Medium with bullet kit (CC-3118, Cambrex, UK)   8
  A-549         DMEM, 10% FBS                                                12
  Neutrophils   RPMI medium 1640, 10% FBS                                    1
  Monocytes     RPMI medium 1640, 10% FBS                                    1

DMEM: Dulbecco\'s modified Eagles medium; F12: nutrient mixture; EGF: epidermal growth factor; FBS: fetal bovine serum; RPMI: Roswell Park Memorial Institute.

Epithelial cells of the renal proximal tubule {#ss4}
---------------------------------------------

Human Kidney-2 (HK-2) (American Type Culture Collection (ATCC) CRL-2190) cells are an immortalized proximal tubule epithelial cell line derived from normal adult kidney, thus providing an ideal means to assess the mechanism of proximal tubule cell physiology and pathophysiology ([@CIT0056]).

Epithelial cells of the gastrointestinal tract {#ss5}
----------------------------------------------

The in vitro cells used to represent gastric epithelium were the AGS cell line (ATCC CRL-1739), which is derived from gastric adenocarcinoma ([@CIT0003]). In addition, T84 cells derived from colonic carcinoma were used. These cells have been found to show very similar physiological characteristics to those of normal colon epithelium, both morphologically and functionally ([@CIT0020]).

Epithelial cells of the respiratory tract {#ss6}
-----------------------------------------

Two kinds of cells were used, each one representative of each portion of the respiratory tract: human small airway epithelial cells (representing the conducting portion) and alveolar epithelial cells (representing the respiratory portion).

Human small airway epithelial cells (ScienCell 3230) are located at the interface between the alveoli and the conducting airways. Airway epithelial cells, which form a continuous lining of the airways, have a unique role as a protective physical and functional barrier to deleterious external agents. These cells are ideal cultures for experimental applications in asthma, inhalation toxicology, and pulmonary inflammatory responses ([@CIT0018]).

A549 cells (ATCC CCL-185) are human alveolar basal epithelial cells. A549 cells fall under the squamous subdivision of epithelial cells, which are associated with the diffusion of water, electrolytes, and other substances. The cell line was derived from a lung carcinoma established from an explanted lung tumor ([@CIT0027]).

Human neutrophils and monocytes {#ss7}
-------------------------------

Circulating neutrophils and monocytes were extracted from the whole blood of healthy donors by Histopaque density centrifugation as previously described ([@CIT0006]). Whereas monocytes were stimulated with cobalt ions (10 ppm) at time points up to 48 h, neutrophils were only exposed for up to 24 h due to their shorter half-life.

Preparation and analysis of secreted protein {#ss8}
--------------------------------------------

Enzyme-linked immunosorbent assays (ELISAs) for the detection of "free" IL-8 and MCP-1 were carried out on the supernatant samples according to the manufacturer\'s protocol (Promocell).

Statistics {#ss9}
----------

For studies on chemokine response, the data shown are from 1 of 3 experiments, all of which yielded similar results. For any given experiment, each data point represents the mean + SD of 6 individual cultures. Data were analyzed by one-way ANOVA using Analyze-it software. Only p-values ≤ 0.05 were considered significant.

Results {#ss10}
=======

The results of chemokine secretion by the different cell lines in response to treatment with cobalt ions are summarized in [Table 2](#T2){ref-type="table"}.

###### 

Apprixomate fold increase in chemokine secretion relative to contrtol levels

                        Length of exposure of cell cultures                                                                                                                                                                                                                                            
  --------------------- ------------------------------------- -------------------------------------- ------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- ------------------------------------
  Renal epithelium      2                                     0                                      14 **[^a^](#T2-N1){ref-type="fn"}**   5 **[^a^](#T2-N1){ref-type="fn"}**     16 **[^a^](#T2-N1){ref-type="fn"}**    7 **[^a^](#T2-N1){ref-type="fn"}**     15 **[^a^](#T2-N1){ref-type="fn"}**    7 **[^a^](#T2-N1){ref-type="fn"}**
  Gastric epithelium    2                                     1.2                                    2.5                                   2.5 **[^a^](#T2-N1){ref-type="fn"}**   3.7 **[^a^](#T2-N1){ref-type="fn"}**   3 **[^a^](#T2-N1){ref-type="fn"}**     4 **[^a^](#T2-N1){ref-type="fn"}**     3 **[^a^](#T2-N1){ref-type="fn"}**
  Colonic epithelium    1.8                                   0                                      1.8                                   0                                      4 **[^a^](#T2-N1){ref-type="fn"}**     3.3 **[^a^](#T2-N1){ref-type="fn"}**   6 **[^a^](#T2-N1){ref-type="fn"}**     4 **[^a^](#T2-N1){ref-type="fn"}**
  SAE                   2.5                                   1.3                                    3                                     1.5                                    5 **[^a^](#T2-N1){ref-type="fn"}**     4 **[^a^](#T2-N1){ref-type="fn"}**     8 **[^a^](#T2-N1){ref-type="fn"}**     4 **[^a^](#T2-N1){ref-type="fn"}**
  Alveolar epithelium   1.5                                   0                                      2                                     0                                      2                                      0                                      2                                      2
  Neutrophils           0                                     2.5 **[^a^](#T2-N1){ref-type="fn"}**   2 **[^a^](#T2-N1){ref-type="fn"}**    4 **[^a^](#T2-N1){ref-type="fn"}**     2 **[^a^](#T2-N1){ref-type="fn"}**     4 **[^a^](#T2-N1){ref-type="fn"}**     N/A                                    N/A
  Monocytes             1.5                                   1.6                                    2 **[^a^](#T2-N1){ref-type="fn"}**    3                                      2.5 **[^a^](#T2-N1){ref-type="fn"}**   4                                      2.5 **[^a^](#T2-N1){ref-type="fn"}**   6

**^a^** p \< 0.05

SAE: small airway epithelium; N/A: no available timpe point.

Cobalt ions stimulated IL-8 and MCP-1 secretion in renal epithelial cells {#ss11}
-------------------------------------------------------------------------

Following 12, 24, and 48 h of treatment with cobalt ions (at 10 ppm), renal tubular epithelial cells showed enhanced secretion of both IL-8 and MCP-1 relative to the control sample (p \< 0.001) ([Figure 1](#F1){ref-type="fig"}). A 16-fold maximal increase was observed for IL-8 secretion, whereas the maximal increase for MCP-1 secretion was 7-fold.

![Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human renal tubular epithelial cells (HK-2) at 12, 24 and 48 h. Renal tubule epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion of IL-8 protein post exposure at 12, 24 and 48 h relative to the control sample (a = p \< 0.001). B: There is also a significant increase in the secretion of MCP-1 protein at 12, 24, and 48h compared to negative control (a = p \< 0.001).](ORT-0300-9734-081-756_g001){#F1}

Cobalt ions stimulated secretion of IL-8 and MCP-1 in gastrointestinal epithelial cells {#ss12}
---------------------------------------------------------------------------------------

Following treatment with cobalt ions (10 ppm), gastric epithelial cells showed enhanced secretion of both IL-8 and MCP-1 relative to the control sample (p \< 0.001) ([Figure 2](#F2){ref-type="fig"}). A 4-fold maximal increase was observed for IL-8 secretion and a 3-fold maximal increase was observed for MCP-1 secretion. A similar increase in chemokine secretion was observed in colon epithelial cells. Following 24 and 48 h of treatment with cobalt ions (10 ppm), colon epithelial cells showed enhanced secretion of both IL-8 and MCP-1 relative to the control sample (p \< 0.001) ([Figure 3](#F3){ref-type="fig"}). A 6-fold maximal increase was observed for IL-8, whereas the maximal increase in MCP-1 secretion was 4-fold.

![Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human gastric epithelial cells (AGS). Gastric epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p \< 0.001). B: There is also a significant increase in the secretion of MCP-1 protein at 12, 24, and 48h compared to negative control (a = p \< 0.001).](ORT-0300-9734-081-756_g002){#F2}

![Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human colonic epithelial cells (T-84). Colonic epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p \< 0.001). B: There is also a significant increase in the secretion of MCP-1 protein at 24 and 48h compared to negative control (a = p \< 0.001).](ORT-0300-9734-081-756_g003){#F3}

Cobalt ions stimulated secretion of IL-8 and MCP-1 in small airway epithelial cells but not in alveolar epithelial cells {#ss13}
------------------------------------------------------------------------------------------------------------------------

Following 24 and 48 h of treatment with cobalt ions (10 ppm), maximal increases of 8- and 4-fold were observed in the secretion of IL-8 and MCP-1, respectively, by small airway epithelial cells (p \< 0.001) ([Figure 4](#F4){ref-type="fig"}). An increase in chemokine secretion was observed in alveolar epithelial cells but this increase was not statistically significant (p = 0.06) (Figure 5, supplementary data).

![Cobalt ions (10ppm) induce enhanced secretion of IL-8 and MCP-1 chemokines in human small airway epithelial cells. Human small airway epithelial cells were treated with 10 ppm cobalt ions for 4, 12, 24 and 48h along with a negative control. A: There is a significant increase in the secretion of IL-8 protein post exposure at 24 and 48h relative to the control sample (a = p \< 0.001). B: There is also a significant increase in the secretion of MCP-1 protein at 12, 24 and 48h compared to negative control (a = p \< 0.001).](ORT-0300-9734-081-756_g004){#F4}

Cobalt ions stimulated secretion of IL-8 and MCP-1 in neutrophils and monocytes {#ss14}
-------------------------------------------------------------------------------

Following treatment with cobalt ions (10 ppm), neutrophils showed enhanced secretion of both IL-8 and MCP-1 relative to the control sample (p \< 0.001) (Figure 6, supplementary data). A 2-fold maximal increase was observed for IL-8 whereas the maximal increase in MCP-1 secretion was 4-fold. A similar increase in chemokine secretion was observed in monocytes. Following treatment with cobalt ions (10 ppm), monocytes showed enhanced secretion of both IL-8 and MCP-1 relative to the control sample (p \< 0.001) (Figure 7, supplementary data). A 2.5-fold maximal increase was observed for IL-8 whereas the maximal increase in MCP-1 secretion was 6-fold.

Discussion {#ss15}
==========

Metal-on-metal articulations consist of a cobalt-chromium-molybdenum alloy and are known to release wear particles and corrosion products into the periprosthetic tissue; they are also transported from the joint and distributed systemically ([@CIT0017], [@CIT0064], [@CIT0038]). There is a measurable increase in cobalt ion levels in the serum, erythrocytes, and urine of patients with MoM bearings ([@CIT0017], [@CIT0037], Savarion et al. 2002, [@CIT0008], [@CIT0047], [@CIT0055]).

The potential effects of elevated levels of metal ions are poorly defined. A number of adverse biological reactions have been linked to the dissemination of metal ions, including soft tissue toxicity, hypersensitivity reactions, bone loss, and risk of carcinogenesis ([@CIT0028], [@CIT0060], [@CIT0065], [@CIT0039], [@CIT0043]). In vitro studies have clearly demonstrated that cobalt particles can be highly cytotoxic when produced in high enough concentrations ([@CIT0049]). There is also much concern about the effect of long-term exposure and the potential for chromosomal aberrations in the patient, as well as the risk of passing chromosomal abnormalities to the next generation ([@CIT0012], [@CIT0021], [@CIT0041], Bordner et al. 2004a, [@CIT0052], [@CIT0067]).

The inflammatory response to a foreign material is of particular relevance. This is the area on which we have focused our research. The response to a foreign material involves a cascade of events. The typical inflammatory response is marked by the accumulation of polymorphonuclear leukocytes at the implant site. We have previously demonstrated that osteoblasts play an integral role in the initiation of this process by secreting proinflammatory chemotactic cytokines, which are sufficient to induce the migration of monocytes and neutrophils ([@CIT0054]). However, metal ions are not restricted to the periprosthetic space and they have direct access to other tissues as result of their movement through the blood. In this study, we have investigated the specific chemokine responses in a variety of human cell lines that represent potential systemic targets of cobalt ion toxicity, following exposure to cobalt ions ([@CIT0022], [@CIT0064], IARC Monographs) Chemokines are the major mediators of chemotactic signaling in the recruitment and activation of inflammatory cells ([@CIT0050], [@CIT0062]). IL-8 and MCP-1 are immediate-early stress response chemokines that function to attract neutrophils and monocytes, respectively.

Unlike most organic chemicals, metals cannot be eliminated from tissues by metabolic degradation. Thus, they can only be eliminated from tissues by renal or gastrointestinal excretion ([@CIT0016]). It is widely regarded, although without evidence-based research, that MoM bearing surfaces are contraindicated in patients with chronic renal failure. In such cases, there is a potential for elevated cobalt levels within the circulation as a result of reduced excretion ([@CIT0007]). However, of equal concern is the effect that cobalt ions have on renal tissue and whether this effect contributes to renal failure in itself. In light of this, we explored the effect of exposure of proximal tubule epithelial cells to cobalt ions. In this study, we have demonstrated for the first time that cobalt ions enhance protein secretion of IL-8 and MCP-1 in renal proximal tubule epithelial cells. The enhanced secretion was substantial, representing a 16-fold and 7-fold increase, respectively, compared to control levels.

Proinflammatory mediators recruit neutrophils and monocytes to the site of insult, which drive the inflammatory response. In the setting of chronic renal failure, the added insult of a further inflammatory stimulus may be sufficient to tip the balance into a vicious circle of reduced excretion and increased circulating levels of cobalt ions. The effect may also be compounded by the fact that neutrophils and monocytes, having been recruited, also give rise to enhanced IL-8 and MCP-1 secretion following exposure to cobalt ions (10 ppm). Whether this is sufficient to induce full renal failure remains to be seen, but it is certainly an area of concern and warrants further research.

Urban et al. have previously demonstrated the dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with a hip or knee replacement following retrieval studies ([@CIT0064]). The gastrointestinal tract is intimately related to these three routes of dissemination, via the portal venous system and lymphatic drainage (Strandring 2008). In the present study, elevated secretion of these proinflammatory chemokines was seen in gastric and colon epithelium. Gastric epithelium showed a 4-fold and 3-fold maximal enhanced secretion of IL-8 and MCP-1, respectively, while colon epithelium showed a maximal 6-fold increase in IL-8 secretion and a 4-fold increase in MCP-1 secretion. It is difficult to assess the importance of this enhanced secretion from gastrointestinal epithelium. A link may perhaps be drawn between this and another chronic relapsing inflammatory condition that can occur in the gastrointestinal tract, inflammatory bowel disease. This disease is characterized by continuous infiltration of affected tissue by inflammatory cells from the circulation. This influx results in further tissue-destructive inflammatory processes. The recruitment and activation of immunocytes is mediated by chemokines, including IL-8 and MCP-1 ([@CIT0063], [@CIT0048]). Chemokine secretion is low or non-existent in resting cells but rapidly becomes upregulated during inflammation ([@CIT0045]). The potential therefore exists for quiescent inflammatory bowel disease to become reactivated as a result of an inflammatory insult, thus perpetuating the disease process ([@CIT0048]). Is it then possible that exposure to high levels of cobalt ions in an individual with inflammatory bowel disease may precipitate a relapse of the inflammatory condition. This is simply a theory, and to date there have been no case reports to corroborate this. It is certainly something to consider in a young patient with inflammatory bowel disease requiring a total hip replacement, perhaps as a result of steroid-induced avascular necrosis of the hip ([@CIT0040]).

Frequent contact with inhaled cobalt from occupational exposure has been shown to cause an increased incidence of asthma and chronic inflammatory pulmonary conditions, either from the particles themselves or from solubilized cobalt ions ([@CIT0051], IARC Monographs). The toxic responses of the respiratory system in metal workers are largely related to inhalation exposure, and are therefore difficult to extrapolate to the vascular route. The respiratory system can be differentiated into two major parts: a conducting portion, consisting of structures that deliver air to the lungs, and a respiratory portion, consisting of structures within the lungs where oxygen is exchanged for carbon dioxide in the blood. The respiratory system has lining epithelia, supporting structures, glands, and other features that are characteristic of each part. The blood flow to the intraparenchymal airways is predominately from the bronchial circulation ([@CIT0004]). As a result, cobalt ions bound to proteins have the potential to come in contact with respiratory epithelium through systemic transmission. Our experiments demonstrate that exposure of small airway epithelial cells to cobalt ions can give rise to an 8-fold increase in IL-8 secretion and a 4-fold increase in MCP-1 secretion. Regarding human alveolar epithelial cells, roughly a 2-fold (maximal) increase in both IL-8 and MCP-1 secretion was observed, but this did not reach statistical significance. These results suggest that the conduction portion of the respiratory system induces an inflammatory response following exposure to cobalt ions while the respiratory portion remains relatively quiescent. Once again, the significance of these data in the clinical setting is unknown and to date there have been no case reports documenting any deterioration in chronic pulmonary conditions following MoM hip replacement. Further work is required to determine the long-term implications of elevated cobalt ion levels in patients with pulmonary disease.

Finally, we explored the effect of exposure of monocytes and neutrophils found within the bloodstream to cobalt ions. We found that monocytes have a rapid response to cobalt ions, inducing the secretion of IL-8 and MCP-1 at 4, 12, 24, and 48 h. Likewise, neutrophils showed a significant increase in secretion of these cytokines. These cells are found both in the circulation and deposited in tissues. They appear to have dual roles as responders to inflammation and recruiters of further leukocytes once stimulated by cobalt ions, thereby perpetuating the inflammatory cascade.

Metallic debris may exist as particles, in ionic form, or as inorganic salts. In this study, we used cobalt ions at a concentration of 10 ppm. The exact concentration of these ions in the periprosthetic space and systemically remains unclear, as there has been variation in study design, in the sources of samples (serum, whole blood, erythrocytes, and urine), and in the method of laboratory analysis ([@CIT0015]). This concentration has been used in vitro by other authors in assessing the effect of cobalt ions on macrophages ([@CIT0013], [@CIT0015], [@CIT0034], [@CIT0053], [@CIT0023]). Serum blood levels are less than 10 ppm; however, these higher levels may be seen in patients with "runaway" wear (see below) or in the setting of renal failure ([@CIT0035], [@CIT0042]). There is recent evidence to suggest that cobalt levels are influenced by factors such as the type, design, and positioning of the implant ([@CIT0057], [@CIT0008], [@CIT0001]). The position of the implant, which is influenced by the skill of the surgeon, plays a major role in the degree of metal ion release. Brodner reported a 10- to 53-fold increase in cobalt levels in patients with an acetabular cup inclination of between 58° and 63° ([@CIT0010]). The classical "run-in" period is well recognized with MoM prostheses, as peak serum levels of cobalt show a 10-fold increase at six months relative to the preoperative levels ([@CIT0002], [@CIT0019]). These peaks are followed by a gradual decline over the next 15 months as the bearing surface enters "steady-state" wear. [@CIT0005] have also described the concept of "runaway" wear, which is a puzzling phenomenon that can result in a 2- to 19-fold increase in wear in prostheses compared to identical bearings ([@CIT0005]).

In summary, the data presented here demonstrate the potent bioactivity of cobalt ions in a variety of systemic cell lines. This process is most likely representative of an overall toxic effect of high-dose exposure to cobalt ions. The significance of these findings has particular relevance in the context of patients undergoing hip replacement surgery with pre-existing renal failure, where there is a greater degree of exposure to high levels of cobalt ions due to reduced excretion. It may also be important in cases where the hip implant cup inclination is placed in excessive abduction or where "runaway" wear is experienced. In addition, due consideration should be given to the choice of bearing surface in patients with inflammatory bowel disease due to the possibility of triggering a relapse.
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###### 

Click here for additional data file.
